Relief Hldg Stock
StockStockPrice
Frequently asked questions
What is Relief Hldg's market capitalization?
What is the Earnings Per Share (EPS) for Relief Hldg?
What is Relief Hldg's revenue over the trailing twelve months?
What is the EBITDA for Relief Hldg?
What is the free cash flow of Relief Hldg?
How many employees does Relief Hldg have, and what sector and industry does it belong to?
What is the free float of Relief Hldg's shares?
Financials
Market Cap
$105.42MEPS (TTM)
-$4.217Free Float
9.65MRevenue (TTM)
$9.74MEBITDA (TTM)
-$10.17MFree Cashflow (TTM)
-$11.88MInformation
RELIEF THERAPEUTICS Holding SA is a Switzerland-based biopharmaceutical company. The Company’s objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. It specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications. RLF-100 is being investigated in two placebo-controlled U.S. phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. Its RLF-100 is also used for pulmonary sarcoidosis. The Company is also involved in the clinical development of RLF-100 that is in planning stage for other indications in acute and chronic lung diseases.
36
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker